Intrinsiqs

Is Enanta Pharmaceuticals, Inc. overvalued?

Enanta Pharmaceuticals, Inc. (ENTA) — key valuation metrics and fundamentals.

No verdict
Price
$12.62
Fair value
—
Current P/E
—
Normal P/E
22.2
Market cap
$366.8M
Dividend yield
0.0%
Return on equity
-61.8%
Sector
Healthcare

See the full interactive analysis →

Fair value compares ENTA's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.